A comprehensive review of hormonal and biological therapies for endometriosis: latest developments
Open accessThe DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Endometriosis is a chronic benign estrogen-dependent disease characterized by the presence of endometriotic glands and stroma outside the uterine cavity. Although combined hormonal contraceptives and progestins, currently available first-line treatments for endometriosis, are efficacious and well tolerated for treating disease-related pain, some women experience partial or no improvement of pain or its recurrence is frequent after discontinuation of the therapies. For these reasons, new drugs are under investigation for the treatment of endometriosis. AREAS COVERED: This review aims to give to the reader a complete and updated overview of hormonal and biological therapies for the treatment of endometriosis, underlining the latest developments in this field of research. EXPERT OPINION: Among the new drugs investigated, late clinical trials on gonadotropin-releasing hormone (GnRH) antagonists and aromatase inhibitors (AIs) have demonstrated the most promising results. For this reason, elagolix, a new GnRH-antagonist, recently received the approval by the Food and Drug Administration (FDA) for treating pain associated to endometriosis. Other drugs with innovative targets have been identified, but the majority of these compounds have only been evaluated in pre-clinical studies or early clinical trials. Thus, a further extensive clinical research is necessary to better elucidate their pharmacologic characteristics, their efficacy, and safety for the treatment of this benign chronic disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
1 retracted
Laparoscopic surgery for pelvic pain associated with endometriosis
Jacobson, T. Z., Duffy, J. M., Barlow, D. H., Koninckx, P. R., & Garry, R. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001300.pub2 · Cited by 219
RetractedESHRE guideline: management of women with endometriosis
Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D'Hooghe, T., De Bie, B., Heikinheimo, O., Horne, A. W., Kiesel, L., Nap, A., et al. (2014) · Human Reproduction · doi:10.1093/humrep/det457 · Cited by 2,211
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Guba, M., von Breitenbuch, P., Steinbauer, M., Koehl, G., Flegel, S., Hornung, M., Bruns, C. J., Zuelke, C., Farkas, S., Anthuber, M., et al. (2002) · Nature Medicine · doi:10.1038/nm0202-128 · Cited by 1,739
Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
Guerriero, S., Condous, G., van den Bosch, T., Valentin, L., Leone, F. P. G., Van Schoubroeck, D., Exacoustos, C., Installé, A. J. F., Martins, W. P., Abrao, M. S., et al. (2016) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.15955 · Cited by 900
Self-citationClassification and pharmacology of progestins
Schindler, A. E., Campagnoli, C., Druckmann, R., Huber, J., Pasqualini, J. R., Schweppe, K. W., & Thijssen, J. H. H. (2003) · Maturitas · doi:10.1016/j.maturitas.2003.09.014 · Cited by 745
p38 MAPK signalling cascades in inflammatory disease
Herlaar, E., & Brown, Z. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(99)01544-0 · Cited by 564
Consensus on current management of endometriosis
Johnson, N. P., Hummelshoj, L., for the World Endometriosis Society Montpellier Consortium, Abrao, M. S., Adamson, G. D., Allaire, C., Amelung, V., Andersson, E., Becker, C., Birna Árdal, K. B., et al. (2013) · Human Reproduction · doi:10.1093/humrep/det050 · Cited by 558
Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist
Taylor, H. S., Giudice, L. C., Lessey, B. A., Abrao, M. S., Kotarski, J., Archer, D. F., Diamond, M. P., Surrey, E., Johnson, N. P., Watts, N. B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1700089 · Cited by 511 · cited 2×
“Recently, two recent large multicenter, RCT trials demonstrated the efficacy of ELX for treating endometriosis-associated chronic pelvic pain and dysmenorrhea [97].”
Background
Research works printed but not linked: 12
- Brown J, 2017, Cochrane Database Syst Rev, 1, CD004753
- 10.1111/aogs.12326 · DOI · Paper page
- Brown J, 2010, Cochrane Database Syst Rev, CD008475
- Miller JD, 1990, Prog Clin Biol Res, 323, 337
- Dawood MY, 1990, Prog Clin Biol Res, 323, 253
- Agarwal SK, 1997, J Reprod Med, 42, 413
- Minaguchi H, 1986, Prog Clin Biol Res, 225, 211
- Adamson GD, 1994, Int J Fertil Menopausal Stud, 39, 215
- 10.1093/humrep/det457 · DOI · Paper page
- Le Bouedec G, 1991, Rev Fr Gynecol Obstet, 86, 407
- Wang Y, 2013, Int J Clin Exp Pathol, 6, 2824
- Gaytan M, 2006, Histol Histopathol, 21, 541
Cited by
Hormonal treatments for endometriosis: The endocrine background
Vannuccini, S., Clemenza, S., Rossi, M., & Petraglia, F. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09666-w · Cited by 336
Progesterone Actions and Resistance in Gynecological Disorders
MacLean, J. A., & Hayashi, K. (2022) · Cells · doi:10.3390/cells11040647 · Cited by 176
Donnez, J., & Dolmans, M.-M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10051085 · Cited by 182
Reis, F. M., Coutinho, L. M., Vannuccini, S., Batteux, F., Chapron, C., & Petraglia, F. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa009 · Cited by 166
Filip, L., Duică, F., Prădatu, A., Crețoiu, D., Suciu, N., Creţoiu, S. M., Predescu, D. V., Varlas, V. N., & Voinea, S.-C. (2020) · Medicina · doi:10.3390/medicina56090460 · Cited by 154
Metadata
- Authors
- Barra, F., Grandi, G., Tantari, M., Scala, C., Facchinetti, F., & Ferrero, S.
- Affiliations
- Ospedale Policlinico San Martino (IT)
- University of Modena and Reggio Emilia (IT)
- Corresponding author
- Ferrero, Simone
- Venue
- Expert Opinion on Biological Therapy
- Publisher
- Informa UK Limited
- Published
- 2019-02-27
- Volume
- 19
- Issue
- 4
- Pages
- 343-360
- ISSN
- 1471-2598 (ISSN-L)
- 1744-7682
- OpenAlex
- W2913913485
- Cited by
- 69
- References
- 177
- Citations by year
- 2026: 8 · 2025: 3 · 2024: 7 · 2023: 8 · 2022: 16 · 2021: 12 · 2020: 9 · 2019: 5
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Expert Opinion on Biological Therapy (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- endometriosis, hormone therapy, biologic therapy, GnRH antagonist, aromatase inhibitors, elagolix, combined hormonal contraceptives, progestins, endometriosis-associated pain, drug development
- MeSH terms
- Biological Products, Clinical Trials as Topic, Endometriosis, Female, Hormone Antagonists, Humans, Gonadotropin-Releasing Hormone, Progestins, Estrogen Receptor Modulators, Aromatase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. https://app.cochat.ai/papers/10.1080/14712598.2019.1581761
- The paper
- Barra, F., Grandi, G., Tantari, M., Scala, C., Facchinetti, F., & Ferrero, S. (2019). A comprehensive review of hormonal and biological therapies for endometriosis: latest developments. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2019.1581761
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.